Results 11 to 20 of about 84,856 (259)
Risks of colorectal cancer and biliary cancer according to accompanied primary sclerosing cholangitis in Korean patients with ulcerative colitis: a nationwide population-based study [PDF]
Intestinal Research, 2023 Background/Aims We conducted a nationwide population-based study to investigate incidence rates of colorectal and biliary cancers according to accompanying primary sclerosing cholangitis in Korean ulcerative colitis patients.
Eun Hye Oh +5 more
doaj +1 more source
Secondary sclerosing cholangitis as cause of persistent jaundice in patients with severe COVID‐19
Liver international (Print), 2021 Little is known about cholestasis, including its most severe variant secondary sclerosing cholangitis (SSC), in critically ill patients with coronavirus disease 19 (COVID‐19). In this study, we analysed the occurrence of cholestatic liver injury and SSC,
S. Bütikofer +11 more
semanticscholar +1 more source
Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis
Pathologica, 2021 Summary Autoimmune cholestatic liver diseases are rare hepato-biliary disorders characterized by a progressive, inflammatory destruction of bile ducts.
S. Sarcognato +9 more
semanticscholar +1 more source
Primary sclerosing cholangitis with partial steroid responsiveness: a case report
Fujita Medical Journal, 2023 A 69-year-old woman suspected to have IgG4-related sclerosing cholangitis causing bile duct stenosis was transferred from another hospital after diarrhea, eosinophilia, and eosinophilic infiltration were detected and prednisolone was prescribed ...
Satoshi Yamamoto +4 more
doaj +1 more source
Primary sclerosing cholangitis
Digestive Diseases, 2010 Primary sclerosing cholangitis (PSC) is a chronic, cholestatic liver disease caused by diffuse inflammation and fibrosis that can involve the entire biliary tree. It is a progressive disorder which can ultimately lead to biliary cirrhosis, portal hypertension and hepatic failure. PSC is a complex genetic disorder with male predominance.
Williamson, K, Chapman, R
+12 more sources
Clinical diagnostic criteria for IgG4‐related sclerosing cholangitis 2020
Journal of hepato-biliary-pancreatic sciences, 2021 Several years have passed since the clinical diagnostic criteria for IgG4‐related sclerosing cholangitis 2012 were published. New findings and knowledge have accumulated since then.
T. Nakazawa +15 more
semanticscholar +1 more source
Primary sclerosing cholangitis [PDF]
Orphanet Journal of Rare Diseases, 2006 Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease of unknown aetiology characterised by inflammation and fibrosis of the biliary tree. The mean age at diagnosis is 40 years and men are affected twice as often as women. There is a reported annual incidence of PSC of 0.9-1.31/100,000 and point prevalence of 8.5-13.6/100,000. The
Worthington, J, Chapman, R
openaire +9 more sources
Overlap syndrome of primary biliary cholangitis and primary sclerosing cholangitis: two case reports
Journal of Medical Case Reports, 2023 Background Overlap syndrome between primary biliary cholangitis and primary sclerosing cholangitis is an extremely rare condition that has been reported in only few published cases so far in the literature.
Haythem Yacoub +8 more
doaj +1 more source
Gut microbiome in primary sclerosing cholangitis: A review
World Journal of Gastroenterology, 2020 Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease characterized by biliary inflammation and stricturing. Exploration of the pathogenesis of PSC in light of its association with inflammatory bowel disease (IBD) and the “gut-liver”
R. Little +4 more
semanticscholar +1 more source
Clinical Case Reports, 2021 This case of secondary sclerosing cholangitis (SSC‐CIP) emphasizes the need to provide follow‐up care for patients that have recovered from COVID‐19 in order to understand the complexity of SARS‐CoV‐2 associated sequela.
C. Klindt +15 more
semanticscholar +1 more source